Trials / Sponsors / Ophirex, Inc.
Ophirex, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) Snakebite, Envenoming, Snake | Phase 2 | 2023-05-30 |
| Completed | Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite Snakebites, Envenoming, Envenoming, Snake | Phase 2 | 2021-08-15 |
| Terminated | Study of Varespladib in Patients Hospitalized With Severe COVID-19 Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 | Phase 2 | 2021-06-30 |